Victor E. Ortega, M.D., Ph.D.

  1. Internist
  2. Pulmonologist

Departamentos

Grupos especializados

Location

  1. Phoenix, Arizona

Idiomas

EnglishSpanish

Victor E. Ortega, M.D., PhD, is a pulmonary disease specialist and a genetic epidemiologist with a specialty interest in respiratory airways diseases.

His clinical focus includes:

  • Expertise in the characterization and individualized management of asthma, especially asthma that is severe or difficult to control.
  • Expertise in the diagnosis and management of bronchiectasis caused by allergic bronchopulmonary aspergillosis, impaired immunity, and impaired airway ciliary clearance (primary ciliary dyskinesia).
  • Expertise in the diagnosis and management of early-onset chronic obstructive pulmonary disease (COPD), emphysema, and bronchiectasis caused by alpha1-antitrypsin deficiency.
  • Expertise in the diagnosis of undiagnosed or unresolved diseases of the respiratory airways, sometimes through the use of genotyping or gene sequencing technologies.
  • Complex coordination of multi-disciplinary clinical and research teams for the diagnosis, individualized management, and study of unresolved, undiagnosed, and orphan lung airway diseases impacting the airways.

He leads genomic research studies across multiple different network funded by the National Institutes of Health National Heart, Lung, and Blood Institute focused on how variation in an individual's genes can influence or alter the risk for more severe asthma, COPD, emphysema, and impaired response to commonly used drugs (a line of research called pharmacogenetics). His research champions ethnic and racial diversity to improve inclusion in genetic studies focused on understanding health disparities.

  1. Asthma
  2. Bronchiectasis
  1. Bronchoalveolar lavage
  2. Bronchoscopy
  3. Pulmonary function test
  4. Spirometry with bronchodilator
  5. Thoracentesis
  • Asthma, especially asthma that is severe or difficult to control.
  • Bronchiectasis caused by allergic bronchopulmonary aspergillosis, impaired immunity, and impaired airway ciliary clearance (primary ciliary dyskinesia).
  • Early-onset chronic obstructive pulmonary disease (COPD), emphysema, and bronchiectasis caused by alpha1-antitrypsin deficiency.
  • Unresolved, undiagnosed, and orphan lung airway diseases impacting the airways.
Phx

Phoenix, Arizona

  1. 2016
    PhD - Molecular Medicine and Translational Science ProgramWake Forest University Graduate School of Arts and Sciences
  2. 2010
    Fellowship - Pulmonary Diseases and Critical Care MedicineWake Forest Baptist Medical Center
  3. 2005
    Residency - Internal MedicineDepartment of Internal Medicine, Cleveland Clinic Foundation
  4. 2003
    Internship - Internal MedicineDepartment of Internal Medicine, Cleveland Clinic Foundation
  5. 2002
    MD - MedicinePonce School of Medicine
  6. 1998
    BS - ChemistryTulane University

Certifications

  1. 2010
    Critical Care MedicineAmerican Board of Internal Medicine
  2. 2009
    Pulmonary DiseaseAmerican Board of Internal Medicine
  3. 2005
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2021
    Who's WhoAmerican Thoracic Society
  2. 2020
    Honoree, Top Papers Published in 2019Department of Internal Medicine, Wake Forest School of Medicine
  3. 2019
    Recipient, Mid-Career Investigator in Clinical/Population Science AwardWake Forest School of Medicine
  4. 2017
    Medical Honoree - One of the Leaders in the Future of CF in North CarolinaAnnual Master Chef's Event, North Carolina Regional Cystic Fibrosis Foundation
  5. 2014
    National Care Center Quality Award for the Adult Cystic Fibrosis Care CenterCystic Fibrosis Foundation
  6. 2010
    Scholar, Translational Research AcademyTranslational Science Institute, Wake Forest School of Medicine
  7. 2010
    First Prize, Basic Science Poster Presentation4th Annual Resident and Fellow Research Day, Department of Internal Medicine, Wake Forest School of Medicine
  8. 2009
    First Prize, Basic Science Poster Presentation3rd Annual Resident and Fellow Research Day, Department of Internal Medicine, Wake Forest School of Medicine
  9. 2009
    Second Prize6th Annual Respiratory Disease Young Investigators' Forum
  10. 2008
    First Prize, Basic Science Poster Presentation2nd Annual Resident and Fellow Research Day, Department of Internal Medicine, Wake Forest School of Medicine
  11. 2007
    Minority Trainee Travel Award RecipientAmerican Thoracic Society
  12. 2007
    First Prize, Basic Science Poster PresentationFirst Annual Resident and Fellow Research Day, Department of Internal Medicine, Wake Forest School of Medicine
  13. 1998
    Cum Laude HonorsTulane University

Professional memberships

  1. 2023
    Invited ReviewerPublic Private Partnership (PPP) Grant Application, Lung Foundation Netherlands and the Dutch Life Sciences & Health Sector
  2. 2022 - present
    MemberDigital Content Committee, American Thoracic Society
  3. 2021
    Invited ReviewerDutch Research Council Vici Program Grant Application, The Netherlands Organization for Health Research and Development
  4. 2021 - present
    President-Appointed MemberHealth Equity and Diversity Committee, American Thoracic Society
  5. 2021 - present
    MemberAssembly on Allergy, Immunology, and Inflammation Program Committee, American Thoracic Society
  6. 2021 - present
    Participant and Speaker on Genetics, Ancestry, and Distinction from RaceAmerican Thoracic Society Workshop on Race/Ethnicity in Pulmonary Function Testing, American Thoracic Society
  7. 2020 - 2021
    ChairSection on Genetics and Genomics, American Thoracic Society
  8. 2020 - present
    MemberIndependent Data Monitoring Committee (Acknowledged in Weinrich DM, et al. N Engl J Med 2020 [PMID: 33332778]), Regeneron
  9. 2019 - 2020
    Co-ChairSection on Genetics and Genomics, American Thoracic Society
  10. 2019 - present
    Co-ConvenerTrans-Omics for Precision Medicine (TOPMed) Asthma Working Group, NHLBI, National Institutes of Health
  11. 2018 - 2021
    MemberCenter for Precision Medicine, Wake Forest School of Medicine
  12. 2018
    SpeakerStudying Pharmacogenomics in Lung Disease and Critical Illness, International Conference Post-Graduate Course, American Thoracic Society
  13. 2018 - present
    FellowAmerican Thoracic Society
  14. 2017 - 2019
    Task Force ParticipantATS/ERS International Guidelines on Definition, Evaluation and Treatment of Severe Asthma, American Thoracic Society and European Respiratory Society
  15. 2017 - 2019
    Co-ChairClinical Year in Review Program Committee, American Thoracic Society
  16. 2017 - 2018
    MemberNominating Committee, Section on Genetics and Genomics, American Thoracic Society
  17. 2017
    Co-Chair"Omics" of Environmental Lung Disease Mini-Symposium, International Conference, American Thoracic Society
  18. 2015
    Young Investigator ParticipantThird Consensus Conference on the Physician Investigator Workforce, Alliance for Academic Internal Medicine
  19. 2015
    Participant and Speaker on PharmacogeneticsWorkshop on Addressing Respiratory Health Equality in the United States, American Thoracic Society and NIH National Heart, Lung, and Blood Institute
  20. 2010 - present
    MemberAsthmaNet Steering Committee, NHLBI, National Institutes of Health
  21. 2010 - present
    MemberSevere Asthma Research Program (SARP3) Steering Committee, NHLBI, National Institutes of Health
  22. 2010 - present
    MemberSubpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) Steering Committee, NHLBI, National Institutes of Health
  23. 2009 - 2013
    MemberAssembly on Respiratory Structure and Function Program Committee, American Thoracic Society